Hillel Tobias, MD, PhD

Hillel Tobias, MD, PhDHillel Tobias, MD, PhD is Clinical Professor of Medicine and Surgery at New York University School of Medicine and Medical Directore of the Liver Transplant Service at the New York University Langone Medical Center.

Dr. Tobias received his AB at Columbia college and his MD from Washington Unviersity (St. Louis). He completed his internship and residency in Internal Medicine on the NYU Medical Service at Bellevue Hospital. After residency he studied liver disease under the mentorship of Profession Sheila Sherlock at the Royal Free Hospital London, earned his PhD from the University of London, and subsequently was NIH fellow with Drs. Fenton Schaffner and Hans Popper at the Mount Sinai Hospital.

Following his training Dr. Tobias returned to NYU where he practices hepatology, does clinical research in liver disease and serves as Medical Director of the Liver Transplant Service. His research activities have included studies on immunologic aspects of primary biliary cirrhosis, lipid disorders in PBC, viral hepatitis in the drug addict population of New York, hepatotoxic effects of methotrexate, the relationship between cryoglobulinemia and hepatitis, multiple aspects of problems in liver transplantation and numerous clinical trial programs related to treatments for hepatitis B and C, non alcoholic fatty liver disease and liver cancer. Dr. Tobias was also Chairman of the Executive Committee of the “Be Free” Asian American Hepatitis B Program, a study which investigated prevalence, natural history and treatment options for hepatitis B in 10,000 New York Asian Americans.

Dr. Tobias is board certified in Internal Medicine and Gastroenterology and is a Diplomate in Transplant Hepatology. He is a member of the American Association for the Study of Liver Disease, the American Gastroenterology Association, and the European Association for the Study of the Liver. He is a Fellow of the American College of Physicians, Chairman of the National Medical Advisory Committee of the American Liver Foundation, and a member of the Board of the American Liver Foundation.